Clinipace Inc. Selected to Manage Prometheus Laboratories Inc. Oncology Program

Published: Jul 17, 2012

MORRISVILLE, N.C.--(BUSINESS WIRE)--Clinipace Worldwide, a global digital research organization (dCRO), today announced Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, has awarded the company an Oncology Program. Immediate plans are commencing for two metastatic melanoma studies.

Back to news